Gene · 4783
Papers1,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated phosphoproteome and transcriptome data-driven analysis of major transcription-regulatory phosphosites in NFIL3. | Integr Biol (Camb) | 2026 | 42822860 | PubTator, text mining | PubMed |
| E4BP4 interacts with PERK to form a feedback loop mediating cold-induced female reproductive disorders. | Cell Stress Chaperones | 2026 | 42700913 | PubTator, text mining | PubMed |
| Circadian proteolysis by the E3 ubiquitin ligase gp78 controls CYP3A4 activity in human hepatocytes. | Biochem Pharmacol | 2026 | 42567488 | PubTator, text mining | PubMed |
| Intervention with Polyvalent Bacterial Lysate Modulates T Helper Cell Subsets in Polish Children with Grass Pollen-Induced Allergic Rhinitis. | Biomedicines | 2026 | 42512095 | PubTator, text mining | PubMed |
| E4BP4 restrains effector-memory CD8+ T cell responses in systemic lupus erythematosus. | Autoimmunity | 2026 | 42471227 | PubTator, text mining | PubMed |
| D-Box Binding Protein (DBP) as a Circadian Output Regulator: Molecular Mechanisms, Tissue-Specific Functions, and Disease Relevance. | Int J Mol Sci | 2026 | 42353162 | PubTator, text mining | PubMed |
| E4BP4 safeguards brown fat mitochondria from obesity-induced fragmentation via ceramide repression. | EMBO Rep | 2026 | 42332066 | PubTator, text mining | PubMed |
| Clocking immunity: circadian modulation of NK cells and emerging timing perspectives. | Front Immunol | 2026 | 42327792 | PubTator, text mining | PubMed |
| Cellular Heterogeneity in Erectile Dysfunction: An In-silico Analysis Revealing PER1, BHLHE40, NFIL3, and KLF10 as Circadian Rhythm Genes. | Curr Med Chem | 2026 | 42304925 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis deciphers heterogeneity and transcriptional regulatory programs of sepsis with different prognosis. | Biol Direct | 2026 | 42215988 | PubTator, text mining | PubMed |
| The emerging roles of NFIL3 in immunity. | J Immunol | 2026 | 42171337 | PubTator, text mining | PubMed |
| Multi-omics analysis identifies NFIL3 as a hypoxia-associated immune regulator in septic cardiomyopathy. | Front Immunol | 2026 | 42148128 | PubTator, text mining | PubMed |
| A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke. | Neurobiol Dis | 2026 | 42066918 | PubTator, text mining | PubMed |
| Computational-based integrative methylome-transcriptome analysis reveals widespread enhancer hypomethylation in esophageal carcinoma. | Epigenomics | 2026 | 41979132 | PubTator, text mining | PubMed |
| Identification of Prognostic Values of Neutrophil Extracellular Traps-Related Genes in Glioma Based on Bioinformatics. | Immun Inflamm Dis | 2026 | 41943267 | PubTator, text mining | PubMed |
| Neutrophil extracellular Trap-related genes in NAFLD: Biomarkers and therapeutic targets. | Clin Exp Med | 2026 | 41925905 | PubTator, text mining | PubMed |
Establishing an atherosclerosis diagnostic model based on WGCNA and machine learning algorithms with key genes in cholesterol metabolism and ferroptosis, and revealing the regulatory role of HMOX1 in cellular ferroptosis. | Front Cardiovasc Med | 2026 | 41908043 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis and experimental validation reveal the role of circadian rhythm-related genes in the crosstalk between osteoporosis and atherosclerosis. | Mamm Genome | 2026 | 41896290 | PubTator, text mining | PubMed |
| Development and validation of a highly accurate multigene gene expression biomarker to predict chemotherapy response in primary triple-negative breast cancer. | Breast Cancer Res Treat | 2026 | 41885969 | PubTator, text mining | PubMed |
| Transient SUMOylation inhibition in human pre-adipocytes stably imprints a transcriptional beiging fate. | Nucleic Acids Res | 2026 | 41854078 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4783/papers